The subject invention concerns mercaptoalkylacyl compounds of formula (I): ##STR1## The compounds of the subject invention can be used to inhibit matrix metalloproteinases and/or TNF.alpha.- and L-selectin sheddase-mediated diseases including degenerative diseases and cancers. The subject invention also concerns methods of using the compounds of the invention to treat or prevent conditions associated with matrix metalloproteinases or that are mediated by TNF.alpha. or L-selectin sheddase.
本发明涉及公式(I)的巯基烷基酰化合物:##STR1## 本发明的化合物可用于抑制基质
金属
蛋白酶和/或TNFα和L-选择素剪切酶介导的疾病,包括退行性疾病和癌症。本发明还涉及使用本发明的化合物治疗或预防与基质
金属
蛋白酶相关的疾病或由TNFα或L-选择素剪切酶介导的疾病的方法。